Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Chris Wack Avenue Therapeutics shares were up 68% to 29 cents after the company reached final agreement with the U.S. Food and Drug Administration on the...
By Denny Jacob Adicet Bio shares surged 25%, to $2.21, following bullish commentary from the clinical stage biotechnology company on its outlook. The stock...
By Ben Glickman AlloVir will cut about 95% of its current employee base after scrapping three late-stage clinical trials. The cell-therapy developer said in...
By Colin Kellaher Shares of Dyne Therapeutics took flight in premarket trading Wednesday after the clinical-stage muscle-disease company reported positive...
By Colin Kellaher Intensity Therapeutics has received U.S. Food and Drug Administration approval to launch a Phase 3 study of its lead drug candidate...